Arteris, Inc. (NASDAQ:AIP – Get Free Report) VP Paul Alpern sold 4,000 shares of the stock in a transaction dated Tuesday, September 1st. The shares were sold at an average price of $20.77, for a total transaction of $83,080.00. Following the completion of the transaction, the vice president owned 70,733 shares of the company’s stock, valued at $1,469,124.41. This represents a 5.35% decrease in their position. The sale was disclosed in a filing with the Securities & Exchange Commission, which is accessible through this hyperlink.
Arteris Stock Up 3.3%
Shares of NASDAQ AIP opened at $21.37 on Friday. The stock has a market capitalization of $1.05 billion, a price-to-earnings ratio of -24.56 and a beta of 1.91. Arteris, Inc. has a 52 week low of $8.42 and a 52 week high of $50.26. The firm has a 50-day moving average price of $29.78 and a 200 day moving average price of $27.41. The company has a quick ratio of 1.57, a current ratio of 1.57 and a debt-to-equity ratio of 0.03.
Arteris (NASDAQ:AIP – Get Free Report) last issued its earnings results on Thursday, August 6th. The company reported ($0.10) earnings per share (EPS) for the quarter, missing analysts’ consensus estimates of ($0.04) by ($0.06). Arteris had a negative net margin of 46.70% and a negative return on equity of 295.96%. The company had revenue of $24.13 million during the quarter, compared to analysts’ expectations of $23.48 million. Equities research analysts anticipate that Arteris, Inc. will post -0.68 EPS for the current fiscal year.
Institutional Investors Weigh In On Arteris
Wall Street Analyst Weigh In
Several research firms have weighed in on AIP. Roth Capital began coverage on Arteris in a report on Tuesday, August 4th. They issued a “buy” rating and a $40.00 target price on the stock. Oppenheimer started coverage on Arteris in a research note on Thursday, July 16th. They set an “outperform” rating and a $40.00 price target for the company. TD Cowen boosted their price objective on shares of Arteris from $22.00 to $40.00 and gave the stock a “buy” rating in a research report on Wednesday, May 13th. Jefferies Financial Group raised shares of Arteris from a “hold” rating to a “buy” rating and increased their price objective for the company from $35.00 to $50.00 in a research note on Friday, August 7th. Finally, Rosenblatt Securities restated a “buy” rating and set a $38.00 target price on shares of Arteris in a report on Friday, August 7th. Five investment analysts have rated the stock with a Buy rating and one has issued a Sell rating to the company’s stock. According to MarketBeat, Arteris currently has an average rating of “Moderate Buy” and an average price target of $41.00.
View Our Latest Stock Analysis on AIP
About Arteris
Arteris, Inc is a fabless semiconductor intellectual property (IP) company specializing in on-chip interconnect solutions and system IP for advanced integrated circuits. The company’s core products include its FlexNoC network-on-chip (NoC) fabrics, Ncore cache coherent interconnect IP, and CodaCache memory subsystem IP. These technologies enable semiconductor and systems companies to design scalable, energy-efficient chips for applications ranging from automotive and artificial intelligence (AI) to 5G communications and high-performance computing.
Founded in 2003 and headquartered in Santa Clara, California, Arteris serves a global customer base across North America, Europe, and Asia.
Featured Stories
- Five stocks we like better than Arteris
- Revolution Medicines Got Its Breakthrough—What Moves It Next?
- Retail Earnings Just Exposed a Bigger Divide in the U.S. Consumer Economy
- FB Financial’s Southern Expansion and Buybacks Drive Analyst Optimism
- AST SpaceMobile Stock Soared 12%—This Was the Catalyst
Receive News & Ratings for Arteris Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Arteris and related companies with MarketBeat.com's FREE daily email newsletter.
